|
Half of Gloucestershire babies ‘missing out on vital antibodies‘
This is Gloucestershire The latest figures show 50 per cent of new mums stop breastfeeding months before NHS guidelines suggest. Switching to formula milk so soon could be putting their baby’s health at risk, midwives advise, as illness fighting antibodies are not passed on … |
PR Web (press release) |
Monoclonal Antibodies Market – New Industry Research Report is Now Available …
PR Web (press release) A recently added market report by Transparency Market Research on “Monoclonal Antibodies Market – Global Industry Size, Share, Trends, Analysis And Forecast, 2012 – 2018” is now available for pre-order. To browse the report, visit … |
BioSante Pharmaceuticals Receives Two New Patents for Manufacture of …EON: Enhanced Online News (press release)No., 7,632,059, covers methods for manufacturing recombinant antibodies. By incorporating our 2A/Furin technology into antibody-expression …
|
XBiotech Announces Development of A Novel True Human™ Antibody …
PipelineReview.com (press release) True Human™ antibodies, which are cloned directly from a human immune response, are expected to be the safest, best tolerated antibody therapeutics. The Company is now developing a manufacturing process for the antibody, and expects to be ready for … |
Clinical Utility of TSH Receptor AntibodiesJournal of Clinical Endocrinology and MetabolismThyroid Unit (G.B.), Division of Endocrinology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114; Division of Endocrinology, M…
|
TODAY ONLY! Vote Once from Anywhere to Win $17000 for MEandYou …
ProHealth 100,000 krone – that’s $17,000, £11,000 or 13,000 Euros – for MEandYou to fund Drs Fluge and Mella’s Rituximab trial in Norway! Click on the LINK , then on the circle besides MEandYou – and, of course share this with your friends! We are falling behind … |
Spectrum Pharmaceuticals Highlights Six Abstracts of Clinical Data at the 2013 …DailyFinanceThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined …
SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals Highlights …4-traders (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combin…
|
GSK eyes first-line use for leukaemia drug Arzerra
PMLiVE However, the product has been slow to gain traction in the CLL market, mainly because it has been reserved for use as a second-line therapy and has found it hard to displace Roche’s Rituxan/MabThera (rituximab) as the dominant therapy in the anti-CD20 … |
|
FDA’s CFS/ME Drug Development Workshop: Day Two: Afternoon Panels
ProHealth In his discussion of the rituximab study, Dr. Rowe pointed out that results need to be measured within the context of specific outcomes: cognitive improvement, activity, and functional measures. Simply asking patients how they feel compared with how … |